Sage Therapeutics Analyst Ratings
BenzingaApr 26 11:55 ET
SAGE Therapeutics: Hold Rating Amidst Zurzuvae Success and Dalzanemdor Setbacks
TipRanksApr 26 08:35 ET
Balancing Opportunity and Risk: Hold Rating on SAGE Therapeutics Amidst High-Stakes Catalysts and Financial Reassessment
TipRanksApr 26 08:08 ET
SAGE Therapeutics (SAGE) Receives a Hold From RBC Capital
TipRanksApr 26 06:37 ET
Sage Therapeutics Analyst Ratings
BenzingaApr 26 05:27 ET
SAGE Therapeutics' Zurzuvae Sales Exceed Expectations but Uncertainties Prompt Hold Rating
TipRanksApr 26 02:21 ET
Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained
MT NewswiresApr 25 14:33 ET
Hold Rating on SAGE Therapeutics Amid Limited Revenue Prospects and Pipeline Uncertainty
TipRanksApr 25 14:25 ET
Analysts Offer Insights on Healthcare Companies: Lisata Therapeutics (LSTA) and SAGE Therapeutics (SAGE)
TipRanksApr 25 11:30 ET
Sage Therapeutics Analyst Ratings
BenzingaApr 25 07:55 ET
SAGE Therapeutics: Hold Rating Amidst Mixed Financial and Market Signals
TipRanksApr 25 07:55 ET
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG)
TipRanksApr 22 01:31 ET
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE), Poseida Therapeutics (PSTX) and Align Tech (ALGN)
TipRanksApr 18 07:10 ET
SAGE Therapeutics: Hold Rating Reiterated Amid Clinical Trial Setbacks and Uncertainties
TipRanksApr 18 05:25 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
TipRanksApr 17 11:30 ET
BofA Downgrades Sage to Underperform, Cites Failed Parkinson's Study
Seeking AlphaApr 17 11:14 ET
Sage Therapeutics Analyst Ratings
BenzingaApr 17 09:37 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)
TipRanksApr 9 06:40 ET
Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)
TipRanksMar 27 21:50 ET
Sage Therapeutics Analyst Ratings
BenzingaMar 26 06:20 ET
No Data
No Data